Intest Res.  2017 Jan;15(1):5-6. 10.5217/ir.2017.15.1.5.

Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia

Affiliations
  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea. dandy813@ hanmail.net

Abstract

No abstract available.


MeSH Terms

Asia*
Hepatitis*
Inflammatory Bowel Diseases*
Risk Factors*

Cited by  1 articles

Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea
Ji Young Chang, Sung-Ae Jung, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim
Intest Res. 2018;16(4):599-608.    doi: 10.5217/ir.2018.00012.


Reference

1. Biancone L, Pavia M, Del Vecchio Blanco G, et al. Hepatitis B and C virus infection in Crohn's disease. Inflamm Bowel Dis. 2001; 7:287–294. PMID: 11720317.
Article
2. Forns X, Martínez-Bauer E, Feliu A, et al. Nosocomial transmission of HCV in the liver unit of a tertiary care center. Hepatology. 2005; 41:115–122. PMID: 15619236.
Article
3. Salcedo-Mora X, Maté J, Medina J, Nam Cha SJ, Gisbert JP, Moreno-Otero R. Chronic hepatitis C and Crohn's disease: nosocomial infection treatment with PEG-interferon plus ribavirin. Digestion. 2006; 73:210–214. PMID: 16883071.
Article
4. Loras C, Saro C, Gonzalez-Huix F, et al. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol. 2009; 104:57–63. PMID: 19098850.
Article
5. Chevaux JB, Nani A, Oussalah A, et al. Prevalence of hepatitis B and hepatitis C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France. Inflamm Bowel Dis. 2010; 16:916–924. PMID: 19885908.
Article
6. Harsh P, Gupta V, Kedia S, et al. Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India. Intest Res. 2017; 15:97–102.
Article
7. He Y, Xu P, Chen Y, et al. Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China. Int J Clin Exp Med. 2015; 8:8078–8085. PMID: 26221373.
8. Kim ES, Cho KB, Park KS, et al. Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area: inadequate protective antibody levels in young patients. J Clin Gastroenterol. 2014; 48:553–558. PMID: 24162170.
Article
9. Nooredinvand HA, Connell DW, Asgheddi M, et al. Viral hepatitis prevalence in patients with active and latent tuberculosis. World J Gastroenterol. 2015; 21:8920–8926. PMID: 26269682.
Article
10. Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016; 14:111–119. PMID: 27175111.
Article
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr